High Growth Tech Stocks in Asia for July 2025

The Asian tech sector is navigating a dynamic landscape, with regional markets reflecting a mix of resilience and cautious optimism amid ongoing global trade discussions and fluctuating economic indicators. As investors seek opportunities in high-growth tech stocks, it's crucial to consider companies that demonstrate strong innovation potential, adaptability to changing market conditions, and robust financial health.

Top 10 High Growth Tech Companies In Asia

Click here to see the full list of 489 stocks from our Asian High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market capitalization of ₩21.27 billion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to ₩151.65 million. The business focuses on innovative biopharmaceutical products, including long-acting biobetters and antibody-drug conjugates.

ALTEOGEN has demonstrated a robust trajectory in the biotech sector, with earnings surging by 387.3% over the past year, significantly outpacing the industry growth of 47.8%. This performance is underpinned by an aggressive R&D strategy, crucial for maintaining its edge in a highly competitive market. With revenue and earnings forecasted to grow annually at 52.3% and 65.2% respectively, ALTEOGEN is not just keeping pace but setting benchmarks within Asia's high-growth tech landscape. The firm’s strategic focus on innovative biotechnologies positions it well amid evolving industry demands, while a forecasted Return on Equity of 76.4% signals strong managerial efficacy and potential future gains.

• Dive into the specifics of ALTEOGEN here with our thorough health report.

• Review our historical performance report to gain insights into ALTEOGEN's's past performance.

Lens Technology (SZSE:300433)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lens Technology Co., Ltd. focuses on the R&D, production, and sale of structural parts, functional modules, and complete machine assemblies in China with a market cap of CN¥120.16 billion.

Operations: The company generates revenue primarily from electronic component manufacturing, amounting to CN¥71.46 billion.

Lens Technology, a key player in the Asian tech market, has demonstrated robust growth with its revenue and earnings expanding by 18.8% and 25.1% annually, respectively. This performance is significantly bolstered by strategic R&D investments which have proven pivotal in maintaining competitive advantage within the electronics sector. Recently, the company pursued additional capital through a follow-on equity offering of HKD 5.48 billion and seeks to enhance its market presence with a new listing in Hong Kong on July 9th. These moves illustrate Lens Technology's proactive approach to funding innovation and expansion, aligning with broader industry trends towards diversification and technological advancement in consumer electronics components.

• Click here to discover the nuances of Lens Technology with our detailed analytical health report.

• Assess Lens Technology's past performance with our detailed historical performance reports.

AVIC Chengdu Aircraft (SZSE:302132)

Simply Wall St Growth Rating: ★★★★★☆

Overview: AVIC Chengdu Aircraft Company Limited specializes in intelligent measurement and control products for both military and civilian sectors globally, with a market cap of CN¥223.79 billion.

Operations: The company focuses on the development and distribution of advanced measurement and control solutions, catering to both defense and civilian markets across China and internationally.

AVIC Chengdu Aircraft, amidst a dynamic aerospace sector in Asia, has shown promising signs with its robust dividend strategy and significant corporate governance changes. Recently affirming a quarterly dividend of CNY 6.23 per 10 shares and adjusting its bylaws, the company is aligning with shareholder interests while navigating through regulatory landscapes. These strategic moves come at a time when the company reported a sharp revenue drop to CNY 3.31 billion from last year's CNY 17.51 billion, reflecting volatile market conditions yet maintaining a forward-looking stance with planned profitability in three years, indicating an expected annual profit growth far surpassing the market's average.

• Click to explore a detailed breakdown of our findings in AVIC Chengdu Aircraft's health report.

• Explore historical data to track AVIC Chengdu Aircraft's performance over time in our Past section.

Seize The Opportunity

• Unlock our comprehensive list of 489 Asian High Growth Tech and AI Stocks by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com